Search research articles
Contact Us
Filters
Showing results (11-20 of 32) with videos related to
Page
of 4
Sort By:
International Journal of Cancer
|
January 10, 2009
Murine osteosarcoma primary tumour growth and metastatic progression is maintained after marked suppression of serum insulin-like growth factor I
Sung-Hyeok Hong, Joseph Briggs, Rachel Newman, et al.
The American Journal of Surgical Pathology
|
January 4, 2013
Immunohistochemical loss of succinate dehydrogenase subunit A (SDHA) in gastrointestinal stromal tumors (GISTs) signals SDHA germline mutation
Markku Miettinen, Jonathan Keith Killian, Zeng-Feng Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 19, 2009
Randomized trial and pharmacokinetic study of pegfilgrastim versus filgrastim after dose-intensive chemotherapy in young adults and children with sarcomas
Elizabeth Fox, Brigitte C Widemann, Douglas S Hawkins, et al.
Cancer Research
|
September 17, 2005
Expression profiles of osteosarcoma that can predict response to chemotherapy
Tsz-Kwong Man, Murali Chintagumpala, Jaya Visvanathan, et al.
Plos One
|
May 30, 2013
Post-transcriptional dysregulation by miRNAs is implicated in the pathogenesis of gastrointestinal stromal tumor [GIST]
Lorna Kelly, Kenneth Bryan, Su Young Kim, et al.
Nature Reviews. Cancer
|
January 26, 2007
Compressing drug development timelines in oncology using phase '0' trials
Shivaani Kummar, Robert Kinders, Larry Rubinstein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 2013
Cediranib for metastatic alveolar soft part sarcoma
Shivaani Kummar, Deborah Allen, Anne Monks, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 24, 2019
A Phase II Trial of Vandetanib in Children and Adults with Succinate Dehydrogenase-Deficient Gastrointestinal Stromal Tumor
John Glod, Fernanda I Arnaldez, Lori Wiener, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 19, 2008
Designing phase 0 cancer clinical trials
Anthony J Murgo, Shivaani Kummar, Larry Rubinstein, et al.
Cancer Research
|
January 2, 2009
The mechanisms of differential sensitivity to an insulin-like growth factor-1 receptor inhibitor (BMS-536924) and rationale for combining with EGFR/HER2 inhibitors
Fei Huang, Ann Greer, Warren Hurlburt, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 32) with videos related to
Sort By:
Page
of 4
International Journal of Cancer
|
January 10, 2009
Murine osteosarcoma primary tumour growth and metastatic progression is maintained after marked suppression of serum insulin-like growth factor I
Sung-Hyeok Hong, Joseph Briggs, Rachel Newman, et al.
The American Journal of Surgical Pathology
|
January 4, 2013
Immunohistochemical loss of succinate dehydrogenase subunit A (SDHA) in gastrointestinal stromal tumors (GISTs) signals SDHA germline mutation
Markku Miettinen, Jonathan Keith Killian, Zeng-Feng Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 19, 2009
Randomized trial and pharmacokinetic study of pegfilgrastim versus filgrastim after dose-intensive chemotherapy in young adults and children with sarcomas
Elizabeth Fox, Brigitte C Widemann, Douglas S Hawkins, et al.
Cancer Research
|
September 17, 2005
Expression profiles of osteosarcoma that can predict response to chemotherapy
Tsz-Kwong Man, Murali Chintagumpala, Jaya Visvanathan, et al.
Plos One
|
May 30, 2013
Post-transcriptional dysregulation by miRNAs is implicated in the pathogenesis of gastrointestinal stromal tumor [GIST]
Lorna Kelly, Kenneth Bryan, Su Young Kim, et al.
Nature Reviews. Cancer
|
January 26, 2007
Compressing drug development timelines in oncology using phase '0' trials
Shivaani Kummar, Robert Kinders, Larry Rubinstein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 2013
Cediranib for metastatic alveolar soft part sarcoma
Shivaani Kummar, Deborah Allen, Anne Monks, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 24, 2019
A Phase II Trial of Vandetanib in Children and Adults with Succinate Dehydrogenase-Deficient Gastrointestinal Stromal Tumor
John Glod, Fernanda I Arnaldez, Lori Wiener, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 19, 2008
Designing phase 0 cancer clinical trials
Anthony J Murgo, Shivaani Kummar, Larry Rubinstein, et al.
Cancer Research
|
January 2, 2009
The mechanisms of differential sensitivity to an insulin-like growth factor-1 receptor inhibitor (BMS-536924) and rationale for combining with EGFR/HER2 inhibitors
Fei Huang, Ann Greer, Warren Hurlburt, et al.
Page
of 4